Published in Physiol Behav on November 22, 2007
Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci (2009) 2.02
Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol (2008) 1.84
Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res (2009) 1.79
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking. Prog Neurobiol (2009) 1.48
Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res (2009) 1.42
The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol (2014) 1.42
The hypocretins as sensors for metabolism and arousal. J Physiol (2008) 1.35
Multiple roles for orexin/hypocretin in addiction. Prog Brain Res (2012) 1.26
Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry (2009) 1.25
The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res (2009) 1.25
Energy regulatory signals and food reward. Pharmacol Biochem Behav (2010) 1.25
Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) (2010) 1.14
Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J Neurosci (2011) 1.10
Hypocretin/orexin in arousal and stress. Brain Res (2009) 1.03
Optogenetic deconstruction of sleep-wake circuitry in the brain. Front Mol Neurosci (2010) 1.00
The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats. J Addict Med (2010) 0.91
Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists. Bioorg Med Chem Lett (2011) 0.90
Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav (2010) 0.89
A Framework for Quantitative Modeling of Neural Circuits Involved in Sleep-to-Wake Transition. Front Neurol (2015) 0.88
Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. J Med Chem (2013) 0.86
Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci (2014) 0.84
The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci (2013) 0.84
Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice. J Physiol (2013) 0.82
Modulation of mood States as a major factor in relapse to substance use. Front Mol Neurosci (2012) 0.80
Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour. J Physiol (2016) 0.79
Counterregulation of insulin by leptin as key component of autonomic regulation of body weight. World J Diabetes (2014) 0.79
Barratt Impulsivity and Neural Regulation of Physiological Arousal. PLoS One (2015) 0.77
Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression. Eur Neuropsychopharmacol (2011) 0.76
Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study. J Clin Sleep Med (2016) 0.75
How can we begin to measure recovery? Subst Abuse Treat Prev Policy (2010) 0.75
Neuroplastic changes in addiction. Front Mol Neurosci (2014) 0.75
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci (1998) 9.88
Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell (1999) 9.84
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32
Drug abuse: hedonic homeostatic dysregulation. Science (1997) 8.22
The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell (1999) 7.99
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
Reduced number of hypocretin neurons in human narcolepsy. Neuron (2000) 6.94
Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol (1954) 6.65
A role for lateral hypothalamic orexin neurons in reward seeking. Nature (2005) 5.41
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron (2001) 5.09
Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol (2001) 4.88
Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron (2006) 4.39
Localization of a "feeding center" in the hypothalamus of the rat. Proc Soc Exp Biol Med (1951) 3.98
Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron (2003) 3.61
Neuroscience of addiction. Neuron (1998) 3.60
Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) (2003) 3.24
Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21
Fos expression in orexin neurons varies with behavioral state. J Neurosci (2001) 3.08
Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev (1991) 3.07
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci (2001) 2.84
Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci (2005) 2.76
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron (2003) 2.73
Afferents to the orexin neurons of the rat brain. J Comp Neurol (2006) 2.57
The NPY system in stress, anxiety and depression. Neuropeptides (2004) 2.51
Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol (2003) 2.45
Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci (2003) 2.43
The hypocretins: setting the arousal threshold. Nat Rev Neurosci (2002) 2.42
Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41
Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience (2002) 2.26
Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) (2001) 2.25
Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci (2004) 2.13
Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol (2003) 1.98
Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci (2003) 1.89
Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl) (2001) 1.87
Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci (2000) 1.73
Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol (1999) 1.67
Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A (2004) 1.61
Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci (2004) 1.55
The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol (2003) 1.54
The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci (1999) 1.44
Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci (2002) 1.43
Behavioral characterization of neuropeptide Y knockout mice. Brain Res (2000) 1.40
A portrait of the substrate for self-stimulation. Psychol Rev (1981) 1.30
Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci (2002) 1.30
Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci (1999) 1.28
Stress, corticotropin-releasing factor, and drug addiction. Ann N Y Acad Sci (1999) 1.26
Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci (2004) 1.26
Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci (2003) 1.20
Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun (1998) 1.20
Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun (2000) 1.18
Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res (1999) 1.17
Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides (1999) 1.15
Life without neuropeptide Y. Recent Prog Horm Res (1998) 1.15
Feeding response to central orexins. Brain Res (1999) 1.14
CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res (2000) 1.14
Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res (2002) 1.07
Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav (2005) 0.99
Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept (2002) 0.96
Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept (2002) 0.92
Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids. Biochem Biophys Res Commun (2002) 0.88
Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. Eur J Neurosci (2001) 0.86
Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol (2004) 0.85
Orexins: a role in medullary sympathetic outflow. Regul Pept (2000) 0.85
Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett (2000) 0.83
Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol Hung (1999) 0.80
Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science (2009) 8.76
Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature (2007) 8.22
Circuit-breakers: optical technologies for probing neural signals and systems. Nat Rev Neurosci (2007) 5.91
Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc (2010) 4.69
Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron (2004) 3.61
Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci (2010) 3.50
Transgenic mice with a reduced core body temperature have an increased life span. Science (2006) 3.37
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05
The hypocretins: setting the arousal threshold. Nat Rev Neurosci (2002) 2.42
Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J Neurosci (2011) 2.37
Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci (2004) 2.13
Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci (2009) 1.58
Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J Neurosci (2010) 1.45
The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol (2014) 1.42
Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A (2012) 1.41
The hypocretins as sensors for metabolism and arousal. J Physiol (2008) 1.35
Optogenetic disruption of sleep continuity impairs memory consolidation. Proc Natl Acad Sci U S A (2011) 1.32
Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. J Neurosci (2013) 1.26
Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol (2005) 1.25
The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res (2009) 1.25
Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci (2010) 1.21
Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron (2011) 1.18
Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice. J Neurosci (2009) 1.16
Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proc Natl Acad Sci U S A (2010) 1.10
Sleep and metabolism: shared circuits, new connections. Trends Endocrinol Metab (2008) 1.08
Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci (2005) 1.05
The brain hypocretins and their receptors: mediators of allostatic arousal. Curr Opin Pharmacol (2009) 1.03
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc Natl Acad Sci U S A (2013) 1.01
Optogenetic deconstruction of sleep-wake circuitry in the brain. Front Mol Neurosci (2010) 1.00
Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept (2002) 0.96
Somatostatin receptor subtype 4 couples to the M-current to regulate seizures. J Neurosci (2008) 0.95
Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin. Endocrinology (2011) 0.95
Optogenetic investigation of neural circuits in vivo. Trends Mol Med (2011) 0.94
Expression, synaptic localization, and developmental regulation of Ack1/Pyk1, a cytoplasmic tyrosine kinase highly expressed in the developing and adult brain. J Comp Neurol (2005) 0.91
Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake. Am J Physiol Regul Integr Comp Physiol (2005) 0.89
Hypocretins in the control of sleep and wakefulness. Curr Neurol Neurosci Rep (2010) 0.88
Functional wiring of hypocretin and LC-NE neurons: implications for arousal. Front Behav Neurosci (2013) 0.85
The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev (2014) 0.83
Neural integration of reward, arousal, and feeding: recruitment of VTA, lateral hypothalamus, and ventral striatal neurons. IUBMB Life (2011) 0.83
Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation. Circ Res (2013) 0.83
A role for Melanin-Concentrating Hormone in learning and memory. Peptides (2009) 0.83
Repeated in vivo exposure of cocaine induces long-lasting synaptic plasticity in hypocretin/orexin-producing neurons in the lateral hypothalamus in mice. J Physiol (2013) 0.82
The hypocretins and their role in narcolepsy. CNS Neurol Disord Drug Targets (2009) 0.82
Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis. J Immunol (2013) 0.81
Intraventricular administration of neuropeptide S has reward-like effects. Eur J Pharmacol (2011) 0.81
A collection of cDNAs enriched in upper cortical layers of the embryonic mouse brain. Brain Res Mol Brain Res (2004) 0.80
Sleep and metabolism: role of hypothalamic neuronal circuitry. Best Pract Res Clin Endocrinol Metab (2010) 0.80
Optogenetics in psychiatric diseases. Curr Opin Neurobiol (2013) 0.79
Cortistatin promotes and negatively correlates with slow-wave sleep. Eur J Neurosci (2007) 0.79
Optogenetics: opsins and optical interfaces in neuroscience. Cold Spring Harb Protoc (2014) 0.79
Cortistatin as a therapeutic target in inflammation. Expert Opin Ther Targets (2007) 0.79
Cortistatin overexpression in transgenic mice produces deficits in synaptic plasticity and learning. Mol Cell Neurosci (2005) 0.79
Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea. Sleep Breath (2010) 0.77
Overexpression of the human beta-amyloid precursor protein downregulates cortistatin mRNA in PDAPP mice. Brain Res (2004) 0.77
Optogenetics in Freely Moving Mammals: Dopamine and Reward. Cold Spring Harb Protoc (2015) 0.77
[Relationships between sleep and addiction]. Adicciones (2012) 0.76
Effect of cortistatin on tau phosphorylation at Ser262 site. J Neurosci Res (2008) 0.75
Somatostatin, cortistatin and their receptors in health and disease. Foreword. Mol Cell Endocrinol (2008) 0.75
Establishing a fiber-optic-based optical neural interface. Cold Spring Harb Protoc (2014) 0.75
Analgesic effect of the neuropeptide cortistatin in murine models of arthritic inflammatory pain. Arthritis Rheum (2013) 0.75
Light and chemical control of neuronal circuits: possible applications in neurotherapy. Expert Rev Neurother (2014) 0.75
Cortistatin radioligand binding in wild-type and somatostatin receptor-deficient mouse brain. Regul Pept (2005) 0.75
Not asleep, not quite awake. Nat Med (2004) 0.75